AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $74,286,965 | -45.5% | 21,346,829 | 0.0% | 86.51% | -4.7% |
| Q1 2024 | $136,192,769 | -0.9% | 21,346,829 | 0.0% | 90.76% | +4.2% |
| Q4 2023 | $137,473,579 | +176.4% | 21,346,829 | 0.0% | 87.15% | +17.6% |
| Q3 2023 | $49,738,112 | -2.1% | 21,346,829 | 0.0% | 74.10% | -3.2% |
| Q2 2023 | $50,805,453 | +29.3% | 21,346,829 | 0.0% | 76.58% | +19.9% |
| Q1 2023 | $39,278,165 | -3.2% | 21,346,829 | 0.0% | 63.85% | -0.8% |
| Q4 2022 | $40,558,975 | +158.0% | 21,346,829 | +190.6% | 64.38% | +135.6% |
| Q3 2022 | $15,723,000 | -24.4% | 7,346,829 | 0.0% | 27.32% | -7.5% |
| Q2 2022 | $20,792,000 | -45.5% | 7,346,829 | 0.0% | 29.54% | -18.9% |
| Q1 2022 | $38,130,000 | 0.0% | 7,346,829 | 0.0% | 36.42% | 0.0% |
| Q4 2021 | $38,130,000 | – | 7,346,829 | – | 36.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 7,346,829 | $15,723,000 | 27.32% |
| TFG Asset Management GP Ltd | 3,039,381 | $6,504,000 | 0.78% |
| Nantahala Capital Management | 5,215,788 | $11,162,000 | 0.72% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,018,000 | 0.62% |
| HARBOR CAPITAL ADVISORS, INC. | 148,454 | $318,000 | 0.29% |
| DAFNA Capital Management LLC | 496,150 | $1,062,000 | 0.29% |
| Blackstone Inc. | 17,985,611 | $38,489 | 0.14% |
| Ikarian Capital, LLC | 260,087 | $556,000 | 0.11% |
| MYDA Advisors LLC | 100,000 | $214,000 | 0.10% |
| Privium Fund Management B.V. | 113,528 | $253,000 | 0.09% |